Definitive Contract HHSO100201300004C
Award Date
2/28/13
Potential Completion Date
12/31/15
Potential Value
$71M
Awardee
Romark Laboratories, L.C.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Tampa, FL 33607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Roche Laboratories Inc. for the purchase of Tamiflu® (antiviral medication) for the Strategic National Stockpile. The contract is a definitive contract with a firm fixed price of $199,048,013.60 and does not have a set-aside designation. The contract was awarded on September 30, 2009 with a period of performance ending on September 29, 2011. Roche Laboratories Inc....
<p>The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, awarded a Firm Fixed Price Delivery Order contract to MedImmune LLC for "DRUGS AND BIOLOGICALS" with a ceiling value of $2,100,000.00. This contract was issued under the Pandemic Influenza Preparedness and Response 2012-2016 Master IDIQ contract vehicle. The contract does not have a set-aside designation and is scheduled for completion by December 31, 2013.</p>
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $63,239,785.00 definitive contract to Arcturus Therapeutics, Inc. for the procurement of a pandemic influenza vaccine (PandFlu) and a quadrivalent seasonal influenza vaccine (QsFlu). This contract is not a set-aside and supports the Arcturus self-amplifying mRNA-based vaccine platform for rapid pandemic influenza response, a key priority under ASPR's Biomedical...
This is a $35,019,405.00 firm fixed-price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a foreign-owned, for-profit biotechnology company that specializes in pandemic preparedness and response. The purpose of the contract is to procure an influenza A(H2Nx) virus vaccine candidate(s) and conduct related clinical trials. This order is part of a larger $13.4 billion...
The federal contract award HHSO100201000026C was issued by the Department of Health and Human Services (HHS) to Elusys Therapeutics Inc., a for-profit biomedical company, for advanced biomedical research and development. The $138,258,201.80 cost-plus-fixed-fee contract has an ultimate completion date of September 30, 2018. The contract is not designated as a set-aside. Elusys Therapeutics Inc. specializes in developing biomedical products and services, with a focus on advanced technology. The...
Alvogen, Inc. was awarded a $40 million firm fixed price delivery order contract by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to deliver oseltamivir phosphate to the Strategic National Stockpile through August 2024. The contract is being funded through the department's Antiviral Drug Purchase & Distribution program and calls for Alvogen to ship the antiviral drug to storage locations in Morristown, New Jersey through the...
This is a $30,921.83 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor. The contract is for the supply of 4,565,440 units of the pharmaceutical product Nitazoxanide 500 mg tablets. The ultimate completion date is August 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which...
This federal contract award is for the delivery of NITAZOXANIDE 500 MG TABLET 6S to the Defense Logistics Agency (DLA). The $32,519.27 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 15, 2024, with a completion date of November 18, 2024. The contract is a delivery order placed against AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a range of...
This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to Elusys Therapeutics Inc., a for-profit organization and manufacturer of goods. The contract, valued at $44,971,900.00, is for "OTHER FUNCTIONS" and is a Firm Fixed Price Delivery Order with no set-aside designation. Elusys Therapeutics Inc. specializes in biomedical research and development, with a focus on advanced technology. The contract is related to the "ANTHIM" product, which...
This federal contract award, valued at $330,136,246.14, was granted by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to 4J Therapeutics Inc., a self-certified small disadvantaged business. The contract's objective is to demonstrate the versatility and efficacy of 4J Therapeutics' programmable antiviral technology platform by assembling a preclinical package for LNA14, performing a Phase 1a...